In this study, we confirmed that NR5A2 acts as a negative prognostic factor in pancreatic cancer and that NR5A2 promotes cell proliferation, migration, and invasion in pancreatic cancer cells in vitro and in vivo. Here, NR5A2 is linked to pancreatic neoplasm.